Xu Liu
- Immunology top 5%
- Immune Cell Function and Interaction 21
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 7
- T-cell and B-cell Immunology 7
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 18
- Cancer Cells and Metastasis 7
- CAR-T cell therapy research 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Research top 10%
- Biochemistry top 10%
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xu Liu
66 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Immunology 644
- Oncology 734
- Cancer Research 249
- Pulmonary and Respiratory Medicine 292
- Biochemistry 60
Countries citing papers authored by Xu Liu
This map shows the geographic impact of Xu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Liu more than expected).
Fields of papers citing papers by Xu Liu
This network shows the impact of papers produced by Xu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Liu. The network helps show where Xu Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xu Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 21 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 23 | |
| 14 | 2020 | 10 | |
| 15 | 2018 | 14 | |
| 16 | 2017 | 45 | |
| 17 | 2016 | 12 | |
| 18 | 2016 | 58 | |
| 19 | 2014 | 3 | |
| 20 | Relationship among anxiety,depression,well-being index and social support in breast cancer patients | 2013 | 1 |
About Xu Liu
Xu Liu is a scholar working on Immunology, Oncology and Equine, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (21 papers), Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (11 papers), Cancer Cells and Metastasis (7 papers), Immune cells in cancer (7 papers), T-cell and B-cell Immunology (7 papers), CAR-T cell therapy research (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Immunology (644 citations), Oncology (734 citations) and Cancer Research (249 citations). Xu Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zengfu Zhang, Dawei Chen, Jinming Yu, Jizhao Wang, Xixi Zhao, Jingkun Qu, Feidi Wang, Xingcong Ma, Wen Wang and Shuqun Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.